🇺🇸 FSC in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 10

Most-reported reactions

1. Disturbance In Attention — 1 report (10%)
2. Drug Interaction — 1 report (10%)
3. Hyperkalaemia — 1 report (10%)
4. Hypotension — 1 report (10%)
5. Malaise — 1 report (10%)
6. Product Contamination Chemical — 1 report (10%)
7. Product Quality Issue — 1 report (10%)
8. Product Substitution Issue — 1 report (10%)
9. Renal Failure Acute — 1 report (10%)
10. Syncope — 1 report (10%)

Source database →

Frequently asked questions

Is FSC approved in United States?

FSC does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for FSC in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.